Ex vivo expansion of hematopoietic stem cells by cytokines
Open accessThe DOI matches its Crossref record; 73 of the 76 references it cites were found in a registry or an index.
Abstract
Autologous or allogeneic hematopoietic stem cell (HSC) transplantation has been used successfully in the treatment of hematological diseases, neoplasias, primary immunodeficiency diseases, and metabolic disorders of children and adult patients. Historically, the bone marrow (BM) has represented the main source of HSCs in pediatric and adult individuals. However, in many cases, a suitable donor is hardly found, thus limiting the applicability of this lifesaving treatment. This difficulty has led to a search for alternative sources of HSCs for use in human transplantations. Two sources of human HSCs have been identified: cord blood (CB) and peripheral blood (PB). PB is considered to be practical sources of HSCs, especially because methods exist which can mobilize significant numbers of stem/progenitor cells into circulation after administration of G-CSF. However, the poor mobilization happens sometimes, and more importantly, concerns about donor safety have been apprehended because of splenic rupture during GCSF application [1]. HSCs derived from CB have many advantages for transplantation, but the recipient is restricted to pediatric patients because of its small volume. These inconveniences have been considered to be resolved if ex vivo expansion of HSCs would turn out to reality. Recently, the identification, cloning, and production of recombinant cytokines together with the identification and purification of HSCs and progenitor cells have greatly increased our understanding of the hematopoietic system. As a result of these fundamental discoveries, many investigators are now attempting ex vivo manipulation of HSCs for potential therapeutic purposes. In general, the objectives of these manipulations are to expand HSCs responsible for long-term hematopoietic repopulation. This review will summarize the present understandings of the roles of cytokines for expansion of human HSCs, together with the development of assay systems to reflect human HSC activity correctly. Moreover, therapeutic applications for ex vivo expanded HSCs will also be discussed [2–4].
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We used a human ex vivo cell culture system to expand undifferentiated HSCs [25,26] derived from umbilical cord blood and verified the phenotypical and physiological properties of HSC-derived myeloid DCs [1,27].”
From PKCδ-Induced PU.1 Phosphorylation Promotes Hematopoietic Stem Cell Differentiation to Dendritic Cells (2011) · cites this paper as [25]
Citations
Cites
1 retracted
Brugger, W., Heimfeld, S., Berenson, R. J., Mertelsmann, R., & Kanz, L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330503 · Cited by 345
RetractedRAG-1-deficient mice have no mature B and T lymphocytes
Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., & Papaioannou, V. E. (1992) · Cell · doi:10.1016/0092-8674(92)90030-g · Cited by 2,931
A severe combined immunodeficiency mutation in the mouse
Bosma, G. C., Custer, R. P., & Bosma, M. J. (1983) · Nature · doi:10.1038/301527a0 · Cited by 2,207
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
Shinkai, Y. (1992) · Cell · doi:10.1016/0092-8674(92)90029-c · Cited by 2,150
Interleukin-6 family of cytokines and gp130
Kishimoto, T., Akira, S., Narazaki, M., & Taga, T. (1995) · Blood · doi:10.1182/blood.v86.4.1243.bloodjournal8641243 · Cited by 1,272 · cited 1×
“IL-6 is a member of the IL-6 cytokine family, which also includes IL-11, ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), oncostatin M (OSM), and cardiotropin-1 (CT-1) [37].”
BackgroundMultiple defects in innate and adaptive immunologic function in NOD/LtSz- scid mice.
Shultz, L. D., Schweitzer, P. A., Christianson, S. W., Gott, B., Schweitzer, I. B., Tennent, B., McKenna, S., Mobraaten, L., Rajan, T. V., Greiner, D. L., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.180 · Cited by 1,223
Ikebuchi, K., Wong, G. G., Clark, S. C., Ihle, J. N., Hirai, Y., & Ogawa, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9035 · Cited by 802 · cited 1×
“IL-6 and IL-3 induce synergistically the proliferation of murine pluripotent hematopoietic progenitors in vitro [42].”
BackgroundYoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Hirata, M., Yamagami, T., Nakahata, T., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.407 · Cited by 635
Self-citationThe kit Ligand, Stem Cell Factor
Galli, S. J., Zsebo, K. M., & Geissler, E. N. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60508-8 · Cited by 633
A newly discovered class of human hematopoietic cells with SCID-repopulating activity
Bhatia, M., Bonnet, D., Murdoch, B., Gan, O. I., & Dick, J. E. (1998) · Nature Medicine · doi:10.1038/2023 · Cited by 609 · cited 2×
“The term SCID-repopulating cell (SRC) has been utilized to describe the reconstitution activity of the human HSCs engrafted in SCID.”
Method
Cited by
Vrtovec, B., Poglajen, G., Lezaic, L., Sever, M., Domanovic, D., Cernelc, P., Socan, A., Schrepfer, S., Torre-Amione, G., Haddad, F., et al. (2013) · Circulation Research · doi:10.1161/circresaha.112.276519 · Cited by 273
“In CD34 cell culture, the addition of IL-6 to early-acting cytokines was associated with decreased long-term repopulating capacity of the cells despite the increased cellular expansion.(24) Based on a similar mechanism, increased IL-6 levels could probably suppress myocardial homing of CD34 cell in patients with DCM.”
BackgroundChua, K.-N., Chai, C., Lee, P.-C., Tang, Y.-N., Ramakrishna, S., Leong, K. W., & Mao, H.-Q. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.06.017 · Cited by 251
Jing, D., Fonseca, A. V., Alakel, N., Fierro, F. A., Muller, K., Bornhauser, M., Ehninger, G., Corbeil, D., & Ordemann, R. (2010) · Haematologica · doi:10.3324/haematol.2009.010736 · Cited by 230
“The best defined culture medium for HSC expansion is supplemented with cytokines such as fetal liver tyrosine kinase-3 ligand (FLT3-L), stem cell factor (SCF), interleukin-3 (IL-3) and thrombopoietin (TPO).(13,14) Interestingly, mesenchymal stromal cells (MSC), which are characterized by multidifferentiation potential…”
BackgroundModification of hematopoietic stem cell fate by 5aza 2′deoxycytidine and trichostatin A.
Milhem, M., Mahmud, N., Lavelle, D., Araki, H., DeSimone, J., Saunthararajah, Y., & Hoffman, R. (2004) · Blood · doi:10.1182/blood-2003-07-2431 · Cited by 195
Rivera-Mulia, J. C., Buckley, Q., Sasaki, T., Zimmerman, J., Didier, R. A., Nazor, K., Loring, J. F., Lian, Z., Weissman, S., Robins, A. J., et al. (2015) · Genome Research · doi:10.1101/gr.187989.114 · Cited by 168
“…Excellence in Molecular Hematology, stimulated to proliferate and differentiate in vitro toward myeloid and erythroid lineages (see Supplemental Methods) according to established protocols (Mayani et al. 1993; Heike and Nakahata 2002; Manz et al. 2002; Mahajan et al. 2009; Migliaccio et al. 2009).”
BackgroundMethod
Metadata
- Authors
- Heike, T., & Nakahata, T.
- Affiliations
- Kyoto University (JP)
- Corresponding author
- Heike, Toshio
- ORCID
- Nakahata, Tatsutoshi
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 1592
- Issue
- 3
- Pages
- 313-321
- ISSN
- 0167-4889 (ISSN-L)
- OpenAlex
- W2090190145
- Cited by
- 116
- References
- 76
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 11 · 2016: 6 · 2015: 4 · 2014: 6 · 2013: 3 · 2012: 5
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3947 d)
- Locations
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- hematopoietic stem cells, ex vivo expansion, cytokines, stem cell culture, hematopoiesis
- MeSH terms
- Animals, Bone Marrow Cells, Carrier Proteins, Cytokinins, Cytological Techniques, Fetal Blood, Hematopoiesis, Hematopoietic Stem Cells, Humans, Interleukin-3, Membrane Proteins, Plant Proteins, Thrombopoietin, Interleukin-6, Cytokines, Hematopoietic Stem Cell Transplantation, Antigens, CD34, Cell Lineage, Stem Cell Factor, Receptors, Interleukin-6, Models, Animal, Arabidopsis Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ex vivo expansion of hematopoietic stem cells by cytokines. https://app.cochat.ai/papers/10.1016/s0167-4889(02)00324-5
- The paper
- Heike, T., & Nakahata, T. (2002). Ex vivo expansion of hematopoietic stem cells by cytokines. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. https://doi.org/10.1016/s0167-4889(02)00324-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.